Alpha Compute Corp
ALP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.05M
Close$
$2.03
37.2% downside
Current Fair Value
37.2% downsideOvervalued by 37.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.05 Million |
|---|---|
| Enterprise Value | $-616,577.00 |
| Earnings per Share | $-209 |
| Beta | 0.63 |
| Outstanding Shares | 326,137 |
Return
| Return on Equity | 5501.63% |
|---|---|
| Return on Assets | -304.13% |
| Return on Invested Capital | -659.38% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -1.08 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 24, 2026
EPS Estimate
$-5.00
Consensus analyst estimateRevenue Estimate
$1.69 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 25, 2026
EPS Estimate
$-3.50
Consensus analyst estimateRevenue Estimate
$5.33 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Portage Biotech Inc
22 employees
CEO: Brittany Kaiser
Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.